세계의 심폐 바이패스 장비 시장 : 제품, 용도, 최종 사용자별 예측(2025-2030년)

The Cardiopulmonary Bypass Equipment Market was valued at USD 306.91 million in 2023, expected to reach USD 319.92 million in 2024, and is projected to grow at a CAGR of 4.38%, to USD 414.51 million by 2030.

Cardiopulmonary bypass (CPB) equipment is critical in cardiac surgeries, facilitating blood circulation and oxygenation during procedures that require heart-lung function support. This equipment is indispensable in surgeries like coronary artery bypass grafting, heart valve repair, and heart transplants. As the global prevalence of cardiovascular diseases rises due to lifestyle factors and an aging population, the demand for CPB equipment continues to increase. Hospitals, cardiac institutes, and ambulatory surgical centers form the primary end-use sectors for this market. Key growth drivers include advancements in technology such as minimally invasive surgery, improved patient safety outcomes, and the rising number of healthcare facilities in developing regions. However, market expansion is constrained by factors like high costs of equipment, stringent regulatory requirements, and the need for skilled operators. Addressing these challenges through innovative research and development can open new avenues: for instance, exploring automated or AI-integrated systems to enhance precision and reduce human error, and developing cost-efficient models suitable for emerging markets. Additionally, with the advent of telehealth and remote healthcare solutions, there could be potential in integrating CPB data into broader patient management systems for enhanced post-operative care. Opportunities also exist in enhancing customer service through training programs for technicians and surgeons on advanced equipment usage, thereby ensuring optimal service delivery. However, competition remains stiff with established players dominating the market, posing entry barriers for new entrants. Companies should focus on continuous product innovation, mergers and acquisitions for market penetration, and strategic partnerships with healthcare facilities to solidify their market position. Thus, while challenges exist, they can be mitigated by adopting a strategic approach centered on technological innovation and market adaptation, providing promising avenues for business growth within the CPB equipment landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiopulmonary Bypass Equipment Market

The Cardiopulmonary Bypass Equipment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of cardiovascular diseases globally
  • Increasing demand for minimally invasive surgical procedures
  • Growing healthcare expenditure and government initiatives to improve healthcare infrastructure
• Market Restraints
  • High cost associated with cardiopulmonary bypass equipment
• Market Opportunities
  • Integration of artificial intelligence for monitoring and predictive analysis
  • Ongoing focus on research and development to develop innovative and cost-effective products
• Market Challenges
  • Stringent regulatory requirements for product approval

Porter's Five Forces: A Strategic Tool for Navigating the Cardiopulmonary Bypass Equipment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiopulmonary Bypass Equipment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiopulmonary Bypass Equipment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiopulmonary Bypass Equipment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiopulmonary Bypass Equipment Market

A detailed market share analysis in the Cardiopulmonary Bypass Equipment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiopulmonary Bypass Equipment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiopulmonary Bypass Equipment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiopulmonary Bypass Equipment Market

A strategic analysis of the Cardiopulmonary Bypass Equipment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiopulmonary Bypass Equipment Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Becton, Dickinson and Company, Beijing ZKSK Technology Co., Ltd., Braile Biomedica, Brightwake Limited, Chalice Medical Ltd., Fresenius Kabi, Getinge AB, Global Blood Resources, LLC, Johnson & Johnson Services, Inc., LivaNova PLC, MAQUET Holding B.V. & Co. KG., MC3 Cardiopulmonary, Medtronic Plc, MicroPort Scientific Corporation, Nipro Corporation, Owgels Group, Precision Medical, Inc., ProCell Surgical Inc., Senko Medical Instrument Manufacturing Co.,Ltd., Sorin Group, Stryker Corporation, Technowood Corporation, Teleflex Incorporated, Terumo Group, Xenios AG, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Cardiopulmonary Bypass Equipment Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Autotransfusion Systems, Heart-Lung Machines, and Oxygenators.
• Based on Application, market is studied across Cardiovascular, Hemodialysis, and Respiratory.
• Based on End-User, market is studied across Dialysis Centers, Hospitals, and Specialty Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of cardiovascular diseases globally
    • 5.1.1.2. Increasing demand for minimally invasive surgical procedures
    • 5.1.1.3. Growing healthcare expenditure and government initiatives to improve healthcare infrastructure
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with cardiopulmonary bypass equipment
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of artificial intelligence for monitoring and predictive analysis
    • 5.1.3.2. Ongoing focus on research and development to develop innovative and cost-effective products
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory requirements for product approval
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Burgeoning usage of oxygenators as it enhances overall procedure safety and effectiveness
  • 5.2.2. End-User: High usage of cardiopulmonary bypass equipment by dialysis centers
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cardiopulmonary Bypass Equipment Market, by Product

• 6.1. Introduction
• 6.2. Autotransfusion Systems
• 6.3. Heart-Lung Machines
• 6.4. Oxygenators

7. Cardiopulmonary Bypass Equipment Market, by Application

• 7.1. Introduction
• 7.2. Cardiovascular
• 7.3. Hemodialysis
• 7.4. Respiratory

8. Cardiopulmonary Bypass Equipment Market, by End-User

• 8.1. Introduction
• 8.2. Dialysis Centers
• 8.3. Hospitals
• 8.4. Specialty Clinics

9. Americas Cardiopulmonary Bypass Equipment Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Cardiopulmonary Bypass Equipment Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Cardiopulmonary Bypass Equipment Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Inspira To Unveil New Line of Cardio-Pulmonary Bypass Devices
  • 12.3.2. Inspira Technologies is Developing the VORTX Blood Oxygenator, a Unique Technology for Saturating Blood With Oxygen and Removing Carbon Dioxide
  • 12.3.3. LivaNova Receives U.S. FDA 510(k) Clearance for Essenz Heart-Lung Machine for Cardiopulmonary Bypass Procedures
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Becton, Dickinson and Company
• 3. Beijing ZKSK Technology Co., Ltd.
• 4. Braile Biomedica
• 5. Brightwake Limited
• 6. Chalice Medical Ltd.
• 7. Fresenius Kabi
• 8. Getinge AB
• 9. Global Blood Resources, LLC
• 10. Johnson & Johnson Services, Inc.
• 11. LivaNova PLC
• 12. MAQUET Holding B.V. & Co. KG.
• 13. MC3 Cardiopulmonary
• 14. Medtronic Plc
• 15. MicroPort Scientific Corporation
• 16. Nipro Corporation
• 17. Owgels Group
• 18. Precision Medical, Inc.
• 19. ProCell Surgical Inc.
• 20. Senko Medical Instrument Manufacturing Co.,Ltd.
• 21. Sorin Group
• 22. Stryker Corporation
• 23. Technowood Corporation
• 24. Teleflex Incorporated
• 25. Terumo Group
• 26. Xenios AG
• 27. Zimmer Biomet Holdings, Inc.